Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1990-1-12
pubmed:abstractText
The clinical efficacy of intravenous amiodarone in terminating sustained ventricular tachycardia and in preventing recurrences of ventricular tachycardia and ventricular fibrillation was evaluated in 26 patients. All of them presented with organic heart disease accompanied by depressed left ventricular function. Intravenous amiodarone terminated spontaneous ventricular tachycardia in eight of 19 patients. Fifteen of the 26 patients had had at least one episode of ventricular tachycardia or ventricular fibrillation each day in the period immediately before the intravenous administration of amiodarone. Amiodarone controlled ventricular tachycardia or ventricular fibrillation in nine of these 15 patients; in three further cases it was successful when supplemented by additional administration of a previously ineffective antiarrhythmic drug and ventricular pacing. Two patients died despite these measures. In one, the amiodarone infusion had to be stopped because of an arrhythmogenic effect. Sustained deterioration of haemodynamic function or of pre-existing intraventricular conduction disturbances was never seen. Intravenous amiodarone was effective in terminating sustained ventricular tachycardia and in preventing frequent episodes of ventricular arrhythmia that were refractory to other antiarrhythmic drugs.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-3609047, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-3940671, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-3997293, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-4770689, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6199755, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6401373, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6409240, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6465016, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6637851, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6689635, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6731300, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-6861767, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-7010975, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-7234654, http://linkedlifedata.com/resource/pubmed/commentcorrection/2590589-980718
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0007-0769
pubmed:author
pubmed:issnType
Print
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
367-71
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
pubmed:affiliation
1 Medizinische Abteilung des Allgemeinen Krankenhauses, Stadt Linz, Austria.
pubmed:publicationType
Journal Article